Cipla | CIPLA - Operating Expenses

Stock Price
1,314.50
Daily Change
-28.50 -2.12%
Monthly
-13.51%
Yearly
-7.47%
Q1 Forecast
1,299.11

Cipla reported INR60.98B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
aTyr Pharma USD 26.94M 6.63M Sep/2025
Cipla INR 60.98B 1.06B Dec/2025
Dr.Reddys Laboratories INR 73.6B 1.79B Dec/2025
Sun Pharmaceuticals INR 111.11B 6.97B Sep/2025
UPL INR 105.85B 21.33B Sep/2025